XCMR Advances the Future of Biodefense
at the CWMD/MCDC Winter Medical & WMD Countermeasure Symposium

XCMR presented its innovative infection prevention platform, EMITR™, and next-generation PPE solutions at the CWMD/MCDC 2024 Winter Medical & WMD Countermeasure Symposium.

The company’s focus on UV-C technology, data fusion, and AI aligns with the symposium’s goals of rapid prototyping and maturing counter-WMD and medical countermeasure efforts.

XCMR’s solutions address the critical need for advanced biodefense and biosecurity capabilities to protect against evolving threats.

About the Symposium

The CWMD/MCDC Winter Medical & WMD Countermeasure Symposium, jointly hosted by the Countering Weapons of Mass Destruction (CWMD) Consortium and the Medical CBRN Defense Consortium (MCDC), serves as a crucial platform for accelerating the development and deployment of solutions against chemical, biological, radiological, and nuclear (CBRN) threats. The event fosters collaboration between industry, academia, and government, focusing on rapid prototyping and maturing technologies that enhance preparedness and response capabilities.

XCMR’s presentation: EMITR™ and Next-Generation PPE

The Electromagnetic Energy for Infection Transmission Resiliency (EMITR™) platform and its next-generation personal protective equipment (PPE) solutions, are designed to focus on Near-field Infection Protection (NIP™) and Surgical Site Infection Prevention (xIP). The presentation highlighted XCMR’s commitment to revolutionizing biodefense and biosecurity through cutting-edge technology and innovative approaches.

Highlights of XCMR’s presentation:

  • XCMR’s EMITR™ Platform: The EMITR™ platform combines UV-C irradiation, data fusion, and AI to enable proactive and adaptive infection prevention strategies. This comprehensive approach aims to enhance infection transmission resiliency at a global scale.
  • Near-Field Infection Protection (NIP™): XCMR’s NIP™ technology creates an “invisible bubble” of protection against aerosol transmission of pathogens in close-contact environments. This solution addresses the limitations of traditional PPE and offers enhanced protection for individuals in various settings.

  • Surgical Site Infection Prevention (xIP): XCMR also showcased its xIP technology, designed to combat surgical site infections (SSIs) by combining surface and air decontamination methods. This innovation addresses the growing concern of antimicrobial resistance and aims to reduce healthcare-associated infections.

  • UV-C disinfection mechanism: XCMR emphasized the effectiveness of UV-C irradiation in disrupting DNA/RNA replication and causing protein damage in pathogens. The company highlighted the use of Far UV-C (200-230 nm) and its broad effectiveness against various airborne and surface pathogens.
  • Collaboration and validation: XCMR’s presentation underscored its strong partnerships with academic, commercial, and US Government entities. The company’s successful track record includes securing multiple US government contracts, filing worldwide patents, and presenting at international conferences.

  • Advanced simulation and modeling: XCMR showcased its expertise in complex UV-C-based systems, utilizing electro-optical design and simulation paired with CFD (Computational Fluid Dynamics) analysis for robust engineering design.

XCMR’s participation in the CWMD/MCDC Winter Medical & WMD Countermeasure Symposium highlighted our dedication to advancing biodefense and biosecurity through innovative technologies. The EMITR™ platform, along with our next-generation PPE solutions, demonstrates XCMR’s commitment to creating a safer and healthier future by proactively addressing the challenges posed by infectious diseases and CBRN threats.

Let's Partner.